A Phase I study of 'Tomudex' and gemcitabine in advanced cancer

被引：1
|
作者：
Cripps, C
Batist, G
Dahrouge, S
Fry, D
McQuillan, A
Kolendowicz, R
Abugaber, AA
机构：
[1] Ottawa Reg Canc Ctr, Ottawa, ON K1Y 4K7, Canada
[2] Jewish Gen Hosp, Clin Res Unit, Quebec City, PQ, Canada
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81582-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1162
引用
收藏
页码：S289 / S289
页数：1
相关论文
共 50 条
  • [1] Lapatinib/gemcitabine and lapatinib/gemcitabine/oxaliplatin - A phase I study for advanced pancreaticobiliary cancer
    Safran, Howard
    Miner, Thomas
    Resnick, Murray
    Dipetrillo, Thomas
    McNulty, Brendan
    Evans, Devon
    Joseph, Plakyil
    Plette, Angela
    Millis, Robin
    Sears, Dina
    Gutman, Ned
    Kennedy, Teresa
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (02): : 140 - 144
  • [2] A phase I study of erlotinib, bevacizumab and gemcitabine in patients with advanced pancreatic cancer
    Gomez-Martin, C.
    Camara, J. C.
    Cortes, H.
    Jara, C.
    Gravalos, C.
    Rubio, B.
    Amador, M. L.
    Hidalgo, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Phase I study of a treatment with Gemcitabine and docetaxel weekly in advanced pancreatic cancer
    Lueck, A
    Ridwelski, K
    Lippert, H
    ANNALS OF ONCOLOGY, 1998, 9 : 52 - 53
  • [4] Phase I study of treatment with Gemcitabine and Docetaxel weekly in advanced pancreatic cancer
    Ridwelski, K
    Lueck, A
    Fahlke, J
    Lippert, H
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 1025 - 1028
  • [5] Phase I study of defactinib combined with pembrolizumab and gemcitabine in advanced cancer.
    Wang-Gillam, Andrea
    Lockhart, Albert C.
    Tan, Benjamin R.
    Suresh, Rama
    Singh, Preet Paul
    Lim, Kian-Huat
    Morton, Ashley
    Huffman, Jess
    Marquez, Samantha
    Boice, Nicolas
    DeNardo, David G.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [6] Phase I Study of Tomudex and Doxorubicin in Patients with Locally Advanced, Inoperable or Metastatic Cancer (IND.98)
    Investigational New Drugs, 2005, 23 : 377 - 377
  • [7] Phase I study of Tomudex and Doxorubicin in patients with locally advanced, inoperable or metastatic cancer (IND.98)
    Georg A. Bjarnason
    Danielle Charpentier
    Ralph Wong
    Rakesh Goel
    Lynn Douglas
    Wendy Walsh
    Sarah Matthews
    Susan Dent
    Lesley Seymour
    Investigational New Drugs, 2005, 23 : 51 - 56
  • [8] Phase I study of Tomudex and Doxorubicin in patients with locally advanced, inoperable or metastatic cancer (IND.98)
    Bjarnason, GA
    Charpentier, D
    Wong, R
    Goel, R
    Douglas, L
    Walsh, W
    Matthews, S
    Dent, S
    Seymour, L
    INVESTIGATIONAL NEW DRUGS, 2005, 23 (01) : 51 - 56
  • [9] Phase I study of tomudex and doxorubicin in patients with locally advanced, inoperable or metastatic cancer (vol 23, 2005)
    Bjarnason, GA
    INVESTIGATIONAL NEW DRUGS, 2005, 23 (04) : 377 - 377
  • [10] A phase I trial of cabozantinib and gemcitabine in advanced pancreatic cancer
    David B. Zhen
    Kent A. Griffith
    Joshua M. Ruch
    Kevin Camphausen
    Jason E. Savage
    Edward J. Kim
    Vaibhav Sahai
    Diane M. Simeone
    Mark M. Zalupski
    Investigational New Drugs, 2016, 34 : 733 - 739
12345